IGF-1 LR3 (Insulin-Like Growth Factor-1, Long R3) Long-acting insulin-like growth factor-1 (IGF-1) analogue (investigational) Pre-filled pen IGF-1 LR3 is a structurally modified, long-acting analogue of IGF-1 that engages the IGF-1 receptor (IGF-1R) and downstream anabolic cascades such as PI3K/AKT/mTOR and MAPK
Helps neutralize free radicals, support liver detox, and maintain cellular health
Diabetes 1997;46(9):1481-1490
1 2 3 4 5 ""TAARgeting Addiction"-The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference"
You must generally have Part D coverage through either: A stand-alone prescription drug plan A Medicare Advantage plan with drug coverage, such as certain HMO, HMO-POS, or PPO plans Certain Special Needs Plans, employer or union group waiver plans, or LI NET participation You must also meet clinical criteria